ADHD - Combined Type: Clinical Trials

3 trials for ADHD - Combined Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Completed 1

Follow ADHD - Combined Type: new trials by email Literature Review of ADHD - Combined Type trials Research Report on ADHD - Combined Type

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylphenidate in KBG Syndrome: N-of-1 Series
Methylphenidate Hydrochloride, Placebo - Kbg Syndrome, ADHD - Combined Type
Phase 4RecruitingRadboud University Medical Center152024-11-132026-08-11
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
Methylphenidate, Placebo - ADHD - Combined Type
Phase 4RecruitingJohns Hopkins University302021-07-272026-10-27
Attention Deficit Disorder Medication Response Study
OROS-Methylphenidate and placebo for inattentive type pts, OROS-Methylphenidate and placebo for combined type pts - ADHD - Inattentive Type, ADHD - Combined Type
Phase 4CompletedChildren's Hospital Medical Center, Cincinnati1712006-06-012021-05-18

Narrower conditions

Attention Deficit Disorder with Hyperactivity (1)  ·  KBG syndrome (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (1)  ·  Mental Disorders (1)  ·  Neurodevelopmental Disorders (1)

Interventions

Methylphenidate (3)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  Johns Hopkins University (1)  ·  Radboud University Medical Center (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Kristin L Bigos, PhD (1)  ·  Tanya E. Froehlich, MS, MD (1)

Results publications

PMID 29489078

NIH funding

K23MH083881 (1)